DPTAX
Price
$32.83
Change
-$0.39 (-1.17%)
Updated
Feb 21 closing price
Net Assets
132.75M
GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
Ad is loading...

DPTAX vs GFACX

Header iconDPTAX vs GFACX Comparison
Open Charts DPTAX vs GFACXBanner chart's image
BNY Mellon Tax Managed Growth C
Price$32.83
Change-$0.39 (-1.17%)
VolumeN/A
Net Assets132.75M
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
DPTAX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DPTAX vs. GFACX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DPTAX is a Buy and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. DPTAX (133M). DPTAX (0.00) and GFACX (0.00) have matching dividends . DPTAX was incepted earlier than GFACX: DPTAX (27 years) vs GFACX (24 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. DPTAX (1.73). GFACX has a lower initial minimum investment than DPTAX: GFACX (250) vs DPTAX (1000). GFACX annual gain was more profitable for investors over the last year : 10.15 vs. DPTAX (-6.65). GFACX return over 5 years is better than : 32.83 vs. DPTAX (7.85).
DPTAXGFACXDPTAX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years24 years-
Gain YTD2.4982.98084%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets133M304B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year-6.6510.15-66%
Returns for 3 years-7.2117.69-41%
Returns for 5 years7.8532.8324%
Returns for 10 years30.6655.6355%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding